- Home
- NCA vs TKNO Comparison
NCA vs TKNO Comparison
Compare NCA & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCA
- TKNO
- Stock Information
- Founded
- NCA 1987
- TKNO 1996
- Country
- NCA United States
- TKNO United States
- Employees
- NCA N/A
- TKNO N/A
- Industry
- NCA Investment Managers
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- NCA Finance
- TKNO Health Care
- Exchange
- NCA Nasdaq
- TKNO Nasdaq
- Market Cap
- NCA 297.3M
- TKNO 244.7M
- IPO Year
- NCA N/A
- TKNO 2021
- Fundamental
- Price
- NCA $8.63
- TKNO $5.91
- Analyst Decision
- NCA
- TKNO Buy
- Analyst Count
- NCA 0
- TKNO 2
- Target Price
- NCA N/A
- TKNO $5.00
- AVG Volume (30 Days)
- NCA 59.6K
- TKNO 269.2K
- Earning Date
- NCA 01-01-0001
- TKNO 11-07-2024
- Dividend Yield
- NCA 3.92%
- TKNO N/A
- EPS Growth
- NCA N/A
- TKNO N/A
- EPS
- NCA N/A
- TKNO N/A
- Revenue
- NCA N/A
- TKNO $36,347,000.00
- Revenue This Year
- NCA N/A
- TKNO $3.56
- Revenue Next Year
- NCA N/A
- TKNO $13.31
- P/E Ratio
- NCA N/A
- TKNO N/A
- Revenue Growth
- NCA N/A
- TKNO N/A
- 52 Week Low
- NCA $7.77
- TKNO $1.16
- 52 Week High
- NCA $9.12
- TKNO $7.92
- Technical
- Relative Strength Index (RSI)
- NCA 24.54
- TKNO 44.25
- Support Level
- NCA $8.65
- TKNO $6.15
- Resistance Level
- NCA $9.02
- TKNO $7.92
- Average True Range (ATR)
- NCA 0.11
- TKNO 0.69
- MACD
- NCA -0.03
- TKNO -0.17
- Stochastic Oscillator
- NCA 14.83
- TKNO 0.50
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.